Neuromyelitis optica and non-organ-specific autoimmunity

Archives of Neurology

Volumn 65, Issue 1, 2008, Pages 78-83

  Pittock, Sean J ^a   Lennon, Vanda A ^a   De Seze, Jerome ^b   Vermersch, Patrick ^c   Homburger, Henry A ^a   Wingerchuk, Dean M ^d   Lucchinetti, Claudia F ^a   Zéphir, Hélène ^c   Moder, Kevin ^a   Weinshenker, Brian G ^a,e  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d MAYO CLINIC   (United States)

^e Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; HUMAN; MAJOR CLINICAL STUDY; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BIOLOGICAL MARKERS; COHORT STUDIES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FRANCE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOLOGIC TESTS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEUROMYELITIS OPTICA; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME; UNITED STATES;

EID: 38349056680     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2007.17     Document Type: Article

References (24)

1. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107-1114.
2. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106-2112.
3. Zuliani L, Lopez de Munain A, Ruiz Martinez J, Olascoaga J, Graus F, Saiz A. NMO-IgG antibodies in neuromyelitis optica: a report of 2 cases [in Spanish]. Neurologia. 2006;21(6):314-317.
4. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202(4):473-477.
5. Weinshenker BG, Wingerchuk DM, Vukasic S, et al. Neuromyelitis optica IgG predicts relapse following longitudinally extensive transverse myelitis. Ann Neurol. 2006;59(3):566-569.
6. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006;63(3):390-396.
7. April RS, Vansonnenberg E. A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: clinicopathologic report and review of the literature. Neurology. 1976;26(11):1066-1070.
8. Kinney EL, Berdorff RL, Rao NS, Fox LM. Devic's syndrome and systemic lupus erythematosus: a case report with necropsy. Arch Neurol. 1979;36(10):643-644.
9. Mochizuki A, Hayashi A, Hisahara S, Shoji S. Steroid-responsive Devic's variant in Sjögren's syndrome. Neurology. 2000;54(6):1391-1392.
10. Hummers LK, Krishnan C, Casciola-Rosen L, et al. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology. 2004;62(1):147-149.
11. Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis. 2000;59(2):120-124.
12. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998;51(4):1219-1220.
13. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005;64(7):1270-1272.
14. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271-1277.
15. Vitali C, Bombardieri S, Jonsson R, et al; European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554-558.
16. Moder KG. Use and interpretation of rheumatologic tests: a guide for clinicians. Mayo Clin Proc. 1996;71(4):391-396.
17. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485-1489.
18. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125(pt 7):1450-1461.
19. Andrianakos AA, Duffy J, Suzuki M, Sharp JJ. Transverse myelopathy in systemic lupus erythematosus: report of three cases and review of the literature. Ann Intern Med. 1975;83(5):616-624.
20. Piper PG. Disseminated lupus erythematosus with involvement of the spinal cord. J Am Med Assoc. 1953;153(3):215-217.
21. Alexander EL. Neurologic disease in Sjögren's syndrome: a mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle: a clinical review and update of immunopathogenesis. Rheum Dis Clin North Am. 1993;19(4):869-908.
22. Magana SM, Pittock SJ, Lennon VA, Keegan M, Weinshenker BG, Lucchinetti CF. NMO-IgG status in fulminant CNS inflammatory demyelinating disorders (IDD) [abstract P04.059]. Neurology. 2007;68(12)(suppl 1):A160.
23. Misu T, Fujihara K, Nakamura M, et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med. 2006;209(3):269-275.
24. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007;130(pt 5):1194-1205.